Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPEX/4747 stock hub

TPEX/4747 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPEX/4747is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.4B

Taipei Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPEX/4747

In the news

Latest news · TPEX/4747

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E44.8

P25 14.4P50 18P75 31.9

ROE3.1

P25 -16.2P50 0.3P75 9.8

ROIC7.5

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPEX/4747 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

237

Groups with data

Currency

TWD

Showing 237 of 237 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	172
Employees Change	1%
Employees Change Percent	0.58
Enterprise value	TWD 1.5B
Exchange	Taipei Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0004747001
Last refreshed	2026-05-10
Market cap	TWD 2.4B
Price	TWD 53.1
Price currency	TWD
Rev Per Employee	3,312,627.91x
Sector	Healthcare
Sic	2834
Symbol	tpex/4747
Website	https://www.jcpjohnson.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.22%
EV Earnings	28.39x
EV/EBIT	20.71x
EV/EBITDA	16.21x
EV/FCF	198.28x
EV/Sales	2.67x
FCF yield	0.32%
P/B ratio	1.41x
P/E ratio	44.78x
P/S ratio	4.23x
PE Ratio10 Y	25.58x
PE Ratio3 Y	39.75x
PE Ratio5 Y	32x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	12.87%
EBITDA Margin	16.44%
FCF margin	1.34%
Gross margin	40.08%
Gross Profit	TWD 228.3M
Gross Profit Growth	-7.91%
Gross Profit Growth Q	-2.1%
Gross Profit Growth3 Y	3.77%
Gross Profit Growth5 Y	3.51%
Net Income	TWD 53.5M
Net Income Growth	-36.4%
Net Income Growth Years	0%
Net Income Growth3 Y	-6.21%
Net Income Growth5 Y	-3.39%
Pretax Margin	11.12%
Profit Margin	9.39%
Profit Per Employee	TWD 311,076
Profitable Years	7
ROA	2.26
Roa5y	3.61
ROCE	4.29
ROE	3.14
Roe5y	5.54
ROIC	7.54
Roic5y	8.74

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	8.48%
Cagr15y	11.34%
Cagr1y	-22.56%
Cagr3y	0.78%
Cagr5y	13.21%
Div CAGR10	0%
Div CAGR3	-4.35%
Div CAGR5	-1.84%
EPS Growth	-36.21
EPS Growth Years	0
EPS Growth3 Y	-18.12
EPS Growth5 Y	-10.88
FCF Growth	-84.58%
FCF Growth3 Y	-36.54%
OCF Growth	14.04%
OCF Growth Q	-47.26%
OCF Growth10 Y	5.5%
OCF Growth3 Y	-7.19%
OCF Growth5 Y	-0.02%
Revenue Growth	-6.81x
Revenue Growth Q	1.84x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	4.82x
Revenue Growth5 Y	6.09x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.28
Assets	TWD 2.1B
Cash	TWD 1.2B
Current Assets	TWD 1.5B
Current Liabilities	TWD 384.2M
Debt	TWD 261M
Debt EBITDA	TWD 2.79
Debt Equity	TWD 0.15
Debt FCF	TWD 34.07
Equity	TWD 1.7B
Interest Coverage	19.58
Liabilities	TWD 384.4M
Long Term Assets	TWD 636.5M
Long Term Liabilities	TWD 160,000
Net Cash	TWD 890.9M
Net Cash By Market Cap	TWD 36.97
Net Cash Growth	-3.15%
Net Debt EBITDA	TWD -9.51
Net Debt Equity	TWD -0.52
Net Debt FCF	TWD -116
Tangible Book Value	TWD 1.7B
Tangible Book Value Per Share	TWD 37.67
WACC	3.67

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.79
Inventory Turnover	2.07
Net Working Capital	TWD 182.3M
Quick ratio	3.3
Working Capital	TWD 1.1B
Working Capital Turnover	TWD 0.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.04%
Dividend Growth	16.79%
Dividend Growth Years	1%
Dividend per share	TWD 1.05
Dividend Years	16
Dividend Yield	1.98%
Ex Div Date	2025-06-26
Last Dividend	TWD 1.75
Payout Frequency	Annual
Payout Ratio	146.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	125.58%
1Y total return	-22.54%
200-day SMA	61.22
3Y total return	2.35%
50-day SMA	54.86
50-day SMA vs 200-day SMA	50under200
5Y total return	85.91%
All Time High	122.5
All Time High Change	-56.65%
All Time High Date	2023-07-21
All Time Low	11.14
All Time Low Change	376.49%
All Time Low Date	2010-01-08
ATR	1.65
Beta	-0.06
Beta1y	0.19
Beta2y	0.03
Ch YTD	-10.3
High	54.9
High52	80.4
High52 Date	2025-09-23
High52ch	-33.96%
Low	53.1
Low52	50.6
Low52 Date	2026-04-17
Low52ch	4.94%
Ma50ch	-3.21%
Price vs 200-day SMA	-13.26%
RSI	42.06
RSI Monthly	40.01
RSI Weekly	28.45
Sharpe ratio	-1.02x
Sortino ratio	-1.26
Total Return	1.94%
Tr YTD	-10.3
Tr15y	400.72%
Tr1m	-3.8%
Tr1w	-4.32%
Tr3m	-6.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 73.3M
Operating Income Growth	-25.32
Operating Income Growth Q	-34.54
Operating Income Growth3 Y	-3.57
Operating Income Growth5 Y	-0.71
Operating margin	12.87

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26,179,779%
Net Borrowing	140,000,000
Shares Insiders	14.97%
Shares Institutions	0.08%
Shares Out	45,381,000
Shares Qo Q	-2.34%
Shares Yo Y	0.04%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 7.7M
Average Volume	54,403.65x
Bv Per Share	37.67
CAPEX	TWD -64M
Ch10y	38.46
Ch15y	160.1
Ch1m	-3.8
Ch1w	-4.32
Ch1y	-24.68
Ch3m	-6.35
Ch3y	-13.66
Ch5y	42.55
Ch6m	-20.15
Change	-2.57%
Change From Open	-1.48
Close	54.5
Days Gap	-1.1
Depreciation Amortization	20,338,000
Dollar Volume	3,235,914
Earnings Date	2026-05-14
EBIT	TWD 73.3M
EBITDA	TWD 93.7M
EPS	TWD 1.19
F Score	4
FCF	TWD 7.7M
FCF EV Yield	0.5x
FCF Per Share	TWD 0.17
Financing CF	61,529,000
Fiscal Year End	December
Founded	1,959
Graham Number	31.70403
Graham Upside	-40.29
Income Tax	TWD 9.9M
Investing CF	-153,763,000
Is Primary Listing	1
Last Earnings Date	2025-11-11
Last Report Date	2025-12-31
Last Split Date	2014-07-30
Last Split Type	Forward
Lynch Fair Value	TWD 5.93
Lynch Upside	-88.83
Ma150	60.73
Ma150ch	-12.56%
Ma20	53.88
Ma20ch	-1.45%
Net CF	-20,527,000
Next Earnings Date	2026-05-14
Open	53.9
P FCF Ratio	314.6
P OCF Ratio	33.61
Payment Date	2025-07-18
Position In Range	0
Ppne	606,752,000
Price Date	2026-05-08
Price EBITDA	TWD 25.73
Ptbv Ratio	1.41
Relative Volume	1.16x
Revenue	569,772,000x
Tax By Revenue	1.73x
Tax Rate	15.58%
Tr6m	-20.15%
Volume	60,940
Z Score	5.87

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPEX/4747 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.0%

$1.05 annual per share

Payout ratio

+147.0%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-1.8%

1 consecutive years of growth

Total shareholder yield

+1.9%

Next ex-dividend date: 2025-06-26

Performance

TPEX/4747 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPEX/4747?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+15.0%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

TPEX/4747 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

42.1

Neutral momentum band

Price vs 200-day MA

-13.3%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

-1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPEX/4747

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpex/4747 stock rating?

tpex/4747 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpex/4747 analysis?

The full report lives at /stocks/tpex/4747/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpex/4747?

The latest report frames tpex/4747 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpex/4747 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.